合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）杂志CSCD

合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）杂志简介

2025年04月20日 星期日

------/有基金-100.0%--https://www2.cloud.editorialmanager.com/synbio/default2.aspx

《合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）》期刊已被查看： 次

合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）栏目及发文方向

/有基金 100.0%

联系：合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）杂志社

杂志社官网：http://www.keaipublishing.com/en/journals/synthetic-and-systems-biotechnology/

主管单位：中国科学院

主办单位：中国科技出版传媒股份有限公司

地址：

邮编：

邮发：

全年定价：；欢迎广大学者朋友联系合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）杂志社投稿订阅！

注意：本站并非《合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）》杂志社官网，不提供征稿投稿服务，仅整理介绍该杂志内容！投稿请直接咨询杂志社！

合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）征稿须知及文章特色

1、投稿方式：在线投稿。

2、官网网址：

http://www.keaipublishing.com/en/journals/synthetic-and-systems-biotechnology/

https://www.sciencedirect.com/journal/synthetic-and-systems-biotechnology

3、投稿网址：

https://www2.cloud.editorialmanager.com/synbio/default2.aspx

4、出刊日期：季刊，逢季末月出版。

2024年2月26日星期一

《合成和系统生物技术（英文）》作者指南

【官网信息】

Guide for Authors

Types of paper

Contributions falling into the following categories will be considered for publication: Original Research Articles, Reviews, and Short Communications.

Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

BEFORE YOU BEGIN

Ethics in Publishing

For information on Ethics in publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.

Animal experiments

Does your research involve experimentation on animals? If so, please provide name of the ethical committee approving these experiments and confirm authors' compliance with all relevant ethical regulations.

Human subjects

Does your study include human subjects? If so, please provide name of the ethical committee approving these experiments, confirm authors' compliance with all relevant ethical regulations, and confirm that written consent has been obtained from all patients.

Informed consent

If your manuscript is related to clinical study, please provide following pieces of information and state them in your manuscript: 1) date of IRB approval and the approval number, 2) status of informed consent (IC); [e.g. Was written IC required? Was your clinical study approved without IC? If so, the reason why?]

I confirm that I have obtained all consents required by applicable law for the publication of any personal details or images of patients, research subjects or other individuals that are used in the materials submitted to KeAi. I have retained a written copy of all such consents and I agree to provide KeAi with copies of the consents or evidence that such consents have been obtained if requested by KeAi.

Clinical research must include IRB approval and patient consent forms.

Conflict of Interest

All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

……

更多详情：

http://www.keaipublishing.com/en/journals/synthetic-and-systems-biotechnology/guide-for-authors/

杂志收录与荣誉

合成和系统生物技术（英文）（Synthetic and Systems Biotechnology）杂志被以下数据库收录：

知网目次维普目次